Drug recall D-1073-2019
Product
8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02
Reason for recall
Presence of Particulate Matter; glass particulates
Lots and codes
Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 283,400 vials
- Distribution
- United States and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2019
- Terminated
- January 27, 2021
Related products
- NDC 0409-6625 Sodium Bicarbonate · Sodium Bicarbonate 84 mg/mL · Hospira, Inc.